New report on global pharmaceutical anti-counterfeiting technologies

A new report on global pharmaceutical anti-counterfeiting technologies has been released which covers many aspects like forecast, status, market size and trends. The report also mentions the complete information about market players, growth scenarios and the prominent market drivers. The report is segmented according to markets, types, regions and applications.

Anti-duplication technology plays an important role in the identification of counterfeit drugs. Duplicate drugs may include spurious ingredients or adulterants in wrong proportions. Duplication can take place in both generic and branded products. It’s well known that fake drugs pose serious health risks and may lead to imminent or long-term effects. Global pharmaceutical anti-duplication solutions are being used widely as Governments world over have become serious to stop counterfeiting of medicines. Technological advancements in anti-counterfeiting technology will further boost the pharmaceutical market.

The main reasons for the rise of counterfeit drugs are lack of awareness, poor monitoring of supply chains and weak regulations. Developed countries like the USA have implemented RFID (radio-frequency identification) while the European countries believe in the 2D barcodes. The developing nations like India are sensitized about the extent of the problem and have formulated rules mandating barcodes. Even the pharmaceutical companies have got serious and are employing Pharmaceutical Anti-Counterfeiting Technologies in order to eliminate the illegitimate drugs in their supply chain.

While most American companies have implemented RFID (Radio Frequency Identification) their European counterparts still rely on barcodes. Developing countries have assessed the criticality of the situation and have laid down rules related to the same. Pharmaceutical companies in India are implementing different anti-counterfeiting technology to battle duplication.